Fig. 4From: RLS-0071, a dual-targeting anti-inflammatory peptide - biomarker findings from a first in human clinical trialPurified human neutrophil survival in RPMI or PBS in the presence of increasing concentrations of RLS-0071. Neutrophils were incubated with RLS-0071 in PBS for 30 min and then measured for survival with the Cell Counting Kit-8 (CCK8). Higher numerical values result from more live neutrophils present at the end of the incubation periodBack to article page